## ACT: Enact Holdings, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 3.1% below STRENGTH zone (4.0-10.0%); PEG unavailable fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.9% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($38.94)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 1
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Enact Holdings price target raised to $43 from $42 at Keefe Bruyette**
- Source: TipRanks | 20251218T140923 | Somewhat-Bullish | Relevance: 100%
- Keefe Bruyette has increased its price target for Enact Holdings (ACT) to $43 from $42, maintaining a Market Perform rating on the shares. The firm cited continued reasonable constructive views on mortgage insurers, anticipating double-digit book value growth. This update follows recent news of Enact Holdings reporting strong Q3 2025 earnings and securing additional reinsurance coverage.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-18 | Keefe, Bruyette | $43 | $42 | +2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-18 | Keefe, Bruyette | main | Market Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 15 ($0.00M) |
| Sells | 5 ($102.59M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 13.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- Blackrock Inc.: 3.2% (+1.0%)
- Vanguard Group Inc: 2.2% (-2.0%)
- Dimensional Fund Adv: 1.9% (+7.1%)
- First Trust Advisors: 1.0% (+87.9%)
- Qube Research & Tech: 1.0% (+289.4%)

### Key Risks

1. Heavy insider selling: $103M sold (5 transactions in 90 days).
2. High short interest (16.2%, 12.6 days to cover): squeeze risk or crowded bearish bet.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

Forward P/E 8.7x stretched relative to 4% growth. Quality metrics strong (margin 54%). Balance sheet: strong liquidity (6612078000.0x), low leverage (D/E 0.29). Insider selling cluster ($102.6M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $6.0B |
| Beta | 0.52 |
| 52W Range | $30.79 - $40.88 |
| Short Interest | 16.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | N/A |
| Forward P/E | 8.7 |
| Current P/E | 9.0 |
| YoY Growth | 3.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 5.0% to 3.1% (-1.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 0.9pp (needs >4.0% for momentum thesis). MRS_5 (-1.0%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 3.5% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). Elevated volume (1.7x 20MA), institutional activity likely. OFD pattern: -DLH (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.09% (CS: 78) | Neutral |
| RSI_14 | 66.6 | Neutral |
| MACD Histogram | 0.15 | Bullish |
| vs SMA20 | 1.034x | Above |
| vs SMA50 | 1.078x | Above |
| vs SMA200 | 1.110x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $40.40
- **Stop Loss:** $38.94 (3.6% risk)
- **Target:** $41.86 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 616
- **Position Value:** $24,886.40
- **Portfolio %:** 24.89%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-02-04 (Est: $1.10)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.11 | $1.12 | +0.9% |
| 2025Q2 | $1.11 | $1.15 | +3.9% |
| 2025Q1 | $1.09 | $1.10 | +0.9% |
| 2024Q4 | $1.08 | $1.09 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*